About the Company
Boston Scientific Corporation ("BSC"), headquartered in Watertown, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM subcutaneous implantable defibrillator (S-ICD).
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
45000
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BSX News
Boston Scientific Corporation (NYSE:BSX) Q1 2024 Earnings Call Transcript
Boston Scientific Corporation (NYSE:BSX) Q1 2024 Earnings Call Transcript April 24, 2024 Boston Scientific ...
Boston Scientific sees 70% electrophysiology growth after Farapulse pulsed-field ablation launch
As a whole, Boston Scientific reported a 13.8% increase in quarterly revenue, for $3.86 billion in net sales. That outpaced ...
Boston Scientific raises full-year profit forecast on heart devices unit strength
Boston Scientific raised its annual profit forecast and beat Wall Street expectations for first-quarter results, sending the ...
Boston Scientific Announces Results for First Quarter 2024
Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing ...
Loading the latest forecasts...